GLRB variants regulate nearby gene expression in human brain tissues

Area of Science:

• Neurogenetics
• Molecular Psychiatry
• Genomics

Background:

• Genome-wide association studies (GWAS) are crucial for identifying genetic risk factors in complex diseases like panic disorder (PD).
• Understanding the functional impact of identified genetic variants is essential for developing diagnostics and therapeutics.
• Four specific genetic variants (rs78726293, rs191260602, rs17035816, rs7688285) in the GLRB gene have been associated with PD risk.

Purpose of the Study:

• To investigate the regulatory effects of four PD-associated genetic variants on nearby gene expression.
• To explore the functional mechanisms underlying the association between these variants and panic disorder pathogenesis.
• To analyze the impact of these variants on PDGFC, GLRB, and GRIA2 gene expression in human brain tissues.

Main Methods:

• Utilized GTEx (version 6) and Braineac expression quantitative trait loci (eQTLs) datasets.
• Examined the association between the four identified genetic variants and the expression levels of PDGFC, GLRB, and GRIA2 genes.
• Performed statistical analysis to determine significant regulatory relationships.

Main Results:

• In the GTEx dataset, variants rs17035816 and rs7688285 significantly regulated the expression of PDGFC and GLRB genes.
• In the Braineac dataset, variant rs17035816 significantly regulated the expression of GLRB and GRIA2 genes.
• These findings provide evidence for the functional role of specific variants in PD risk.

Conclusions:

• The genetic variants rs17035816 and rs7688285 play a role in regulating the expression of genes implicated in panic disorder.
• This study offers supplementary insights into the molecular mechanisms connecting these genetic variants to PD risk.
• Further research can build upon these findings to explore novel diagnostic and therapeutic targets for panic disorder.